Cargando…

MatchMiner: an open-source platform for cancer precision medicine

Widespread, comprehensive sequencing of patient tumors has facilitated the usage of precision medicine (PM) drugs to target specific genomic alterations. Therapeutic clinical trials are necessary to test new PM drugs to advance precision medicine, however, the abundance of patient sequencing data co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klein, Harry, Mazor, Tali, Siegel, Ethan, Trukhanov, Pavel, Ovalle, Andrea, Vecchio Fitz, Catherine Del, Zwiesler, Zachary, Kumari, Priti, Van Der Veen, Bernd, Marriott, Eric, Hansel, Jason, Yu, Joyce, Albayrak, Adem, Barry, Susan, Keller, Rachel B., MacConaill, Laura E., Lindeman, Neal, Johnson, Bruce E., Rollins, Barrett J., Do, Khanh T., Beardslee, Brian, Shapiro, Geoffrey, Hector-Barry, Suzanne, Methot, John, Sholl, Lynette, Lindsay, James, Hassett, Michael J., Cerami, Ethan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537311/ https://www.ncbi.nlm.nih.gov/pubmed/36202909 http://dx.doi.org/10.1038/s41698-022-00312-5

Ejemplares similares

MatchMiner: a tool for batch navigation among gene and gene product identifiers
por: Bussey, Kimberly J, et al.
Publicado: (2003)

Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer
por: Keller, Rachel B., et al.
Publicado: (2023)

Somatic mutations in CDH1 and CTNNB1 in primary carcinomas at 13 anatomic sites
por: Busch, Evan L., et al.
Publicado: (2017)

Twists and turns from “tumor in tumor” profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosis
por: Terraf, Panieh, et al.
Publicado: (2021)

BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers
por: Abo, Ryan P., et al.
Publicado: (2015)

Automated Network Analysis Identifies Core Pathways in Glioblastoma
por: Cerami, Ethan, et al.
Publicado: (2010)

Tecnología Push en Internet /
por: Cerami, Ethan
Publicado: (1999)

Web services essentials
por: Cerami, Ethan
Publicado: (2002)

OncoThreads: visualization of large-scale longitudinal cancer molecular data
por: Harbig, Theresa A, et al.
Publicado: (2021)

The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine
por: Garofalo, Andrea, et al.
Publicado: (2016)

Toward accurate high-throughput SNP genotyping in the presence of inherited copy number variation
por: MacConaill, Laura E, et al.
Publicado: (2007)

Interactive or static reports to guide clinical interpretation of cancer genomics
por: Gray, Stacy W, et al.
Publicado: (2018)

Endometrial cancer with an EML4-ALK rearrangement
por: Craig, Jeffrey W., et al.
Publicado: (2018)

Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer
por: Ricciuti, Biagio, et al.
Publicado: (2019)

Angiomyolipoma Have Common Mutations in TSC2 but No Other Common Genetic Events
por: Qin, Wei, et al.
Publicado: (2011)

Emerging Evidence for MicroRNAs as Regulators of Cancer Stem Cells
por: Sethi, Aisha, et al.
Publicado: (2011)

cPath: open source software for collecting, storing, and querying biological pathways
por: Cerami, Ethan G, et al.
Publicado: (2006)

The landscape of kinase fusions in cancer
por: Stransky, Nicolas, et al.
Publicado: (2014)

Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patients
por: Moon, Intae, et al.
Publicado: (2023)

Unique transcriptional changes in coagulation cascade genes in SARS-CoV-2-infected lung epithelial cells: A potential factor in COVID-19 coagulopathies
por: FitzGerald, Ethan S., et al.
Publicado: (2020)

Comment on ‘SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung’
por: FitzGerald, Ethan S, et al.
Publicado: (2022)

High Throughput Interrogation of Somatic Mutations in High Grade Serous Cancer of the Ovary
por: Matulonis, Ursula A., et al.
Publicado: (2011)

Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan‐Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors
por: Edelman, Gerald, et al.
Publicado: (2018)

Reducing the carbon footprint of research: experience from the NightLife study
por: Quann, Niamh, et al.
Publicado: (2023)

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
por: Maron, Martin S, et al.
Publicado: (2023)

Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
por: Tarantino, P., et al.
Publicado: (2023)

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Competitive Cell Death Interactions in Pulmonary Infection: Host Modulation Versus Pathogen Manipulation
por: FitzGerald, Ethan S., et al.
Publicado: (2020)

AB569, a Novel, Topical Bactericidal Gel Formulation, Kills Pseudomonas aeruginosa and Promotes Wound Healing in a Murine Model of Burn Wound Infection
por: Barry, Amanda, et al.
Publicado: (2021)

PiHelper: an open source framework for drug-target and antibody-target data
por: Aksoy, Bülent Arman, et al.
Publicado: (2013)

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
por: Deshpande, Vikram, et al.
Publicado: (2011)

Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
por: Maron, Barry J., et al.
Publicado: (2022)

The fuzzy world of precision medicine: deliberations of a precision medicine tumor board
por: McGraw, Sarah A, et al.
Publicado: (2017)

High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma
por: Lee, Jeeyun, et al.
Publicado: (2012)

Genotyping Cancer-Associated Genes in Chordoma Identifies Mutations in Oncogenes and Areas of Chromosomal Loss Involving CDKN2A, PTEN, and SMARCB1
por: Choy, Edwin, et al.
Publicado: (2014)

Agile methods in biomedical software development: a multi-site experience report
por: Kane, David W, et al.
Publicado: (2006)

Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management
por: Burns, Ethan A., et al.
Publicado: (2021)

Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19–associated Coagulopathies
por: FitzGerald, Ethan S., et al.
Publicado: (2021)

Clinical and Molecular Validation of BAP1, MTAP, P53, and Merlin Immunohistochemistry in Diagnosis of Pleural Mesothelioma
por: Chapel, David B., et al.
Publicado: (2022)

End-to-end pipeline for differential analysis of pausing in ribosome profiling data
por: Flanagan, Keegan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eea8eupsbcce2oj1v01kcg6gqu